Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03169842 · ClinicalTrials.gov registry record · NA
Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts
A NA study of Pancreatic Cyst, sponsored by Ochsner Health System.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03169842: Completed NA study of Pancreatic Cyst, sponsored by Ochsner Health System.
NCT03169842 is a NA study of Pancreatic Cyst that has completed, run by Ochsner Health System. The registered enrollment target is 37 participants, below the 548-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03169842, a NA study of Pancreatic Cyst, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the utility of using cyst fluid glucose levels to diagnose mucinous pancreatic cysts during endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) procedures.
Primary Outcome
concentration of cyst fluid glucose based on measurement with bedside glucometer
Conditions Studied
Interventions
- DEVICE pancreatic cyst fluid glucose analysis using a bedside glucometer
Study Locations (1)
Louisiana
- Ochsner Medical Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-05-25 |
| Est. Completion | 2022-04-18 |
| Phase | NA |
What the finished NCT03169842 record still lists
NCT03169842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 548-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Pancreatic Cyst appearing as the primary indexed condition, and to 1 intervention - of which pancreatic cyst fluid glucose analysis using a bedside glucometer is the first listed.
NCT03169842 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT03169842 about?
NCT03169842 is a clinical study titled "Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts". This study evaluates the utility of using cyst fluid glucose levels to diagnose mucinous pancreatic cysts during endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) procedures.
What is the current status of trial NCT03169842?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-05-25. Estimated completion is 2022-04-18.
What conditions does trial NCT03169842 study?
This clinical trial studies the following conditions: Pancreatic Cyst.
What interventions are being tested in trial NCT03169842?
The interventions under investigation include: pancreatic cyst fluid glucose analysis using a bedside glucometer (DEVICE).
Who is sponsoring clinical trial NCT03169842?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03169842 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cyst
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03169842's enrollment target sits among peer trials
37 15th of 18 higher than 4 of 18 other Pancreatic Cyst trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cyst trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
RECRUITING · NA
-
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
COMPLETED · NA
-
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
RECRUITING
-
UCSF PANC Cyst Registry
RECRUITING
-
PROMs After Pancreatectomy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI